Literature DB >> 2424752

Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.

G Grimaldi, P Di Fiore, E K Locatelli, J Falco, F Blasi.   

Abstract

We have investigated the regulation of urokinase (u-PA) mRNA in quiescent mouse fibroblasts and keratinocytes stimulated to divide by the addition of serum or epidermal growth factor (EGF), respectively. Serum stimulation of quiescent fibroblasts (BALB/c 3T3 or Swiss 3T3) results in an early and transient increase of u-PA mRNA level, which precedes by several hours the onset of DNA synthesis. A similar response is elicited by EGF stimulation of quiescent keratinocytes. The increase of u-PA mRNA parallels that of c-myc mRNA, does not require protein synthesis and is at least in part due to increase in template activity of the u-PA gene. Induction of terminal differentiation of mouse keratinocytes results in a decrease of u-PA mRNA which parallels the decrease of thymidine incorporation. In conclusion, variation in the level of u-PA mRNA is seen during G0/G1 transition and correlates with the proliferative state of these normal mouse cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424752      PMCID: PMC1166874          DOI: 10.1002/j.1460-2075.1986.tb04295.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

1.  Tumour promotor induces plasminogen activator.

Authors:  M Wigler; I B Weinstein
Journal:  Nature       Date:  1976-01-22       Impact factor: 49.962

2.  Increased protease levels in transformed cells: a casein overlay assay for the detection of plasminogen activator production.

Authors:  A R Goldberg
Journal:  Cell       Date:  1974-06       Impact factor: 41.582

3.  NH2-terminal sequences of mammalian plasminogens and plasmin S-carboxymethyl heavy (A) and light (B) chain derivatives. A re-evaluation of the mechanism of activation of plasminogen.

Authors:  K C Robbins; P Bernabe; L Arzadon; L Summaria
Journal:  J Biol Chem       Date:  1973-10-25       Impact factor: 5.157

4.  A restriction point for control of normal animal cell proliferation.

Authors:  A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

5.  A quantitative system for assay of malignant transformation by chemical carcinogens using a clone derived from BALB-3T3.

Authors:  T Kakunaga
Journal:  Int J Cancer       Date:  1973-09-15       Impact factor: 7.396

6.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

7.  Regulation of plasminogen activator synthesis in chick embryo fibroblasts infected with avian retroviruses.

Authors:  D B Rifkin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

8.  Plasminogen activator is an apparent lymphocyte mitogen.

Authors:  S D Cohen; E Israel; B Spiess-Meier; M A Wainberg
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

9.  Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration.

Authors:  L Ossowski; J P Quigley; G M Kellerman; E Reich
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

10.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses.

Authors:  L Ossowski; J C Unkeless; A Tobia; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

View more
  17 in total

1.  Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1.

Authors:  M Koziczak; W Krek; Y Nagamine
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester.

Authors:  P Rørth; C Nerlov; F Blasi; M Johnsen
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

3.  An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene.

Authors:  P Verde; S Boast; A Franzè; F Robbiati; F Blasi
Journal:  Nucleic Acids Res       Date:  1988-11-25       Impact factor: 16.971

4.  A cell-type specific and enhancer-dependent silencer in the regulation of the expression of the human urokinase plasminogen activator gene.

Authors:  R Cannio; P S Rennie; F Blasi
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

5.  Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.

Authors:  Hiroto Matsuoka; Thomas H Sisson; Teruaki Nishiuma; Richard H Simon
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-13       Impact factor: 6.914

6.  Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig.

Authors:  A I Cassady; K J Stacey; K A Nimmo; K M Murphy; D von der Ahe; D Pearson; F M Botteri; Y Nagamine; D A Hume
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

Review 7.  Invasion and metastasis.

Authors:  D Boyd
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

8.  Differential protease expression by cutaneous squamous and basal cell carcinomas.

Authors:  A P Sappino; D Belin; J Huarte; S Hirschel-Scholz; J H Saurat; J D Vassalli
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

9.  Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.

Authors:  S N Wagner; M J Atkinson; S Thanner; C Wagner; M Schmitt; O Wilhelm; M Rotter; H Höfler
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

10.  Complex regulation of plasminogen activator inhibitor type-1 (PAI-1) gene expression by serum and substrate adhesion.

Authors:  M P Ryan; S M Kutz; P J Higgins
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.